Evidence map›Paper›PMID 26762399›Full record

ArticleBMC medical imaging2016

A semi-automated measuring system of brain diffusion and perfusion magnetic resonance imaging abnormalities in patients with multiple sclerosis based on the integration of coregistration and tissue segmentation procedures.

Alfredo Revenaz, Massimiliano Ruggeri, Marcella Laganà, Niels Bergsland, Elisabetta Groppo, Marco Rovaris, Enrico Fainardi

Open access · goldAbstract read
In one paragraph

Article in BMC medical imaging, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Alfredo RevenazUnità Operativa di Neuroradiologia, Dipartimento di Neuroscienze e Riabilitazione, Azienda Ospedaliero-Universitaria of Ferrara, Arcispedale S. Anna, Via Aldo Moro 8, 44124, Cona, Ferrara, Italy. alfredo@revenaz.it.
Massimiliano RuggeriConsiglio Nazionale delle Ricerche, 44124, Ferrara, Italy. m.ruggeri@imamoter.cnr.it.
Marcella LaganàMR Research Laboratory, IRCCS Don Gnocchi Foundation ONLUS, Milan, Italy. mlagana@dongnocchi.it.
Niels BergslandMR Research Laboratory, IRCCS Don Gnocchi Foundation ONLUS, Milan, Italy. niels.bergsland@gmail.com.
Elisabetta GroppoSezione di Neurologia, Dipartimento di Scienze Biomediche e Chirurgico Specialistiche, Università di Ferrara, Ferrara, Italy. grplbt@unife.it.
Marco RovarisUnità Operativa di Sclerosi Multipla, Fondazione Don Gnocchi ONLUS, IRCCS S. Maria Nascente, 20148, Milano, Italy. mrovaris@dongnocchi.it.
Enrico FainardiUnità Operativa di Neuroradiologia, Dipartimento di Neuroscienze e Riabilitazione, Azienda Ospedaliero-Universitaria of Ferrara, Arcispedale S. Anna, Via Aldo Moro 8, 44124, Cona, Ferrara, Italy. henryfai@tin.it.
Don Carlo Gnocchi Foundation · ITArcispedale Sant'Anna · ITNational Research Council · ITUniversity of Ferrara · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDiffusion-weighted imaging (DWI) and perfusion-weighted imaging (PWI) abnormalities in patients with multiple sclerosis (MS) are currently measured by a complex combination of separate procedures. Therefore, the purpose of this study was to provide a reliable method for reducing analysis complexity and obtaining reproducible results.

methodsWe implemented a semi-automated measuring system in which different well-known software components for magnetic resonance imaging (MRI) analysis are integrated to obtain reliable measurements of DWI and PWI disturbances in MS.

resultsWe generated the Diffusion/Perfusion Project (DPP) Suite, in which a series of external software programs are managed and harmonically and hierarchically incorporated by in-house developed Matlab software to perform the following processes: 1) image pre-processing, including imaging data anonymization and conversion from DICOM to Nifti format; 2) co-registration of 2D and 3D non-enhanced and Gd-enhanced T1-weighted images in fluid-attenuated inversion recovery (FLAIR) space; 3) lesion segmentation and classification, in which FLAIR lesions are at first segmented and then categorized according to their presumed evolution; 4) co-registration of segmented FLAIR lesion in T1 space to obtain the FLAIR lesion mask in the T1 space; 5) normal appearing tissue segmentation, in which T1 lesion mask is used to segment basal ganglia/thalami, normal appearing grey matter (NAGM) and normal appearing white matter (NAWM); 6) DWI and PWI map generation; 7) co-registration of basal ganglia/thalami, NAGM, NAWM, DWI and PWI maps in previously segmented FLAIR space; 8) data analysis. All these steps are automatic, except for lesion segmentation and classification.

conclusionWe developed a promising method to limit misclassifications and user errors, providing clinical researchers with a practical and reproducible tool to measure DWI and PWI changes in MS.

Indexed as

BrainDiagnostic ImagingDiffusion Magnetic Resonance ImagingHumansImage Processing, Computer-AssistedMagnetic Resonance AngiographyMultiple SclerosisSoftware

Identifiers

PMID26762399
PMCPMC4712616
OpenAlexW2239654213

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.